Achieving virologic suppression is still the primary goal of HIV management, but treatment individualization and optimization should be equally prioritized. There are many reasons to consider switching a suppressive ART regimen that have nothing to do with resistance or treatment failure, including newly approved regimens, personal preference, changes in comorbidities or coinfections, and quality of life. Listen in to learn practical strategies for proactive ART switch, and learn how to guide clinical conversations about ART switch in this podcast, featuring audio from a live webinar hosted by National Clinician Consultation Center experts Daniel Moring-Parris, MD, AAHIVS and Cristina Gruta, PharmD, AAHIVP. For more, visit the program page on our website.Presenters:Daniel Moring-Parris, MD, AAHIVSFamily Medicine Clinician and HIV Specialist, Contra Costa HealthCo-Director, HIV Track, Contra Costa Family Medicine ResidencyConsultant, UCSF National Clinician Consultation CenterMartinez, CaliforniaCristina Gruta, PharmD, AAHIVPPrincipal HIV/HCV Clinical Education Pharmacy SpecialistNational Clinician Consultation CenterClinical PharmacistUCSF 360 Positive Care ClinicAssistant Clinical ProfessorUCSF School of Pharmacy (WOS)San Francisco, CaliforniaLink to program page:https://bit.ly/4ywDm5ZGet access to all of our new podcasts by subscribing to the Decera Clinical Education Infectious Disease Podcast on Apple Podcasts, YouTube Music, or Spotify. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related